` Comparison: LAB, NOVO B - Alpha Spread

L
LAB
vs
NOVO B

Over the past 12 months, LAB has significantly outperformed NOVO B, delivering a return of +26% compared to the NOVO B's 62% drop.

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
LAB
NOVO B
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Valuation
Growth
Profitability
Solvency
Comparing Valuation
Running a multi-layered valuation analysis to compare how attractive each stock is.
Comparing Growth
Financial growth, forecasts, volatility, and historical drawdowns.
Comparing Profitability
Margins, returns on capital, and the consistency of profitability.
Comparing Solvency
Debt levels, liquidity, interest coverage, and bankruptcy risk.
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

L
LAB Intrinsic Value
10.86 EUR
Undervaluation 64%
Intrinsic Value
Price
NOVO B Intrinsic Value
638.27 DKK
Undervaluation 46%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
L
Labiana Health SA
MAD:LAB
3.92 EUR
Novo Nordisk A/S
CSE:NOVO B
345.45 DKK
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
LAB, NOVO B

LAB
NOVO B
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
L
Labiana Health SA
Revenue
Novo Nordisk A/S
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
LAB, NOVO B

LAB
NOVO B
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
L
Labiana Health SA
MAD:LAB
Novo Nordisk A/S
CSE:NOVO B
What is Free Cash Flow?

Gross Margin

LAB
62.5%
NOVO B
84%
LTM 3Y Avg 5Y Avg 10Y Avg
L
Labiana Health SA
Novo Nordisk A/S

Operating Margin

LAB
8.4%
NOVO B
45.8%
LTM 3Y Avg 5Y Avg 10Y Avg
L
Labiana Health SA
Novo Nordisk A/S

Net Margin

LAB
0.4%
NOVO B
35.6%
LTM 3Y Avg 5Y Avg 10Y Avg
L
Labiana Health SA
Novo Nordisk A/S

FCF Margin

LAB
6.3%
NOVO B
19.8%
LTM 3Y Avg 5Y Avg 10Y Avg
L
Labiana Health SA
Novo Nordisk A/S

ROE

LAB
6.5%
NOVO B
79.2%
LTM 3Y Avg 5Y Avg 10Y Avg
L
Labiana Health SA
Novo Nordisk A/S

ROA

LAB
0.5%
NOVO B
26.1%
LTM 3Y Avg 5Y Avg 10Y Avg
L
Labiana Health SA
Novo Nordisk A/S

ROIC

LAB
-91.5%
NOVO B
31.7%
LTM 3Y Avg 5Y Avg 10Y Avg
L
Labiana Health SA
Novo Nordisk A/S

ROCE

LAB
17.3%
NOVO B
62.6%
LTM 3Y Avg 5Y Avg 10Y Avg
L
Labiana Health SA
Novo Nordisk A/S

Solvency Comparison

Balance Sheet Comparison

Stocks Performance

Stocks Performance
LAB, NOVO B

Loading

Performance Gap
LAB, NOVO B

Loading
LAB
NOVO B
Difference
www.alphaspread.com

Performance By Year
LAB, NOVO B

Loading
LAB
NOVO B
Add Stock
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare LAB to other stocks
Unlock Full Access to Alpha Spread
Create Free Account